News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
883,093 Results
Type
Article (88733)
Company Profile (816)
Press Release (793521)
Multimedia
Podcasts (236)
Webinars (35)
Section
Business (233571)
Career Advice (4161)
Deals (39979)
Drug Delivery (176)
Drug Development (91684)
Employer Resources (207)
FDA (18548)
Job Trends (17483)
News (398685)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3053)
Academic (2)
Accelerated approval (56)
Adcomms (40)
Allergies (192)
Alliances (56989)
ALS (232)
Alzheimer's disease (1960)
Antibody-drug conjugate (ADC) (544)
Approvals (18875)
Artificial intelligence (853)
Autoimmune disease (348)
Automation (63)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (243)
Biotechnology (480)
Bladder cancer (211)
Brain cancer (84)
Breast cancer (835)
Cancer (6504)
Cardiovascular disease (547)
Career advice (3596)
Career pathing (52)
CAR-T (379)
CDC (76)
Celiac Disease (3)
Cell therapy (1057)
Cervical cancer (53)
Clinical research (78868)
Collaboration (2336)
Company closure (8)
Compensation (1486)
Complete response letters (105)
COVID-19 (3039)
CRISPR (123)
C-suite (1261)
Cystic fibrosis (166)
Data (8543)
Decentralized trials (3)
Denatured (90)
Depression (190)
Dermatology (96)
Diabetes (660)
Diagnostics (7577)
Digital health (66)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (417)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (315)
Earnings (102470)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138400)
Executive appointments (1184)
FDA (22568)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1913)
Gene editing (269)
Generative AI (89)
Gene therapy (845)
GLP-1 (1261)
Government (5555)
Grass and pollen (8)
Guidances (419)
Healthcare (21243)
HIV (92)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (110)
Immunology and inflammation (351)
Immuno-oncology (113)
Indications (201)
Infectious disease (3432)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (312)
Interviews (821)
IPO (17996)
IRA (61)
Job creations (5207)
Job search strategy (2871)
JPM (73)
Kidney cancer (23)
Labor market (119)
Layoffs (685)
Leadership (52)
Legal (10171)
Liver cancer (110)
Longevity (36)
Lung cancer (867)
Lymphoma (457)
Machine learning (65)
Management (66)
Manufacturing (1200)
MASH (221)
Medical device (15260)
Medtech (15405)
Mergers & acquisitions (23260)
Metabolic disorders (1757)
mRNA (263)
Multiple sclerosis (203)
NASH (24)
Neurodegenerative disease (498)
Neuropsychiatric disorders (126)
Neuroscience (3678)
Neurotech (2)
NextGen: Class of 2026 (7715)
Non-profit (5141)
Now hiring (80)
Obesity (844)
Opinion (371)
Ovarian cancer (242)
Pain (281)
Pancreatic cancer (342)
Parkinson's disease (410)
Partnered (39)
Patents (644)
Patient recruitment (732)
Peanut (69)
People (67923)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24377)
Phase 2 (34259)
Phase 3 (25761)
Pipeline (9544)
Policy (395)
Postmarket research (3559)
Preclinical (10955)
Press Release (72)
Prostate cancer (341)
Psychedelics (68)
Radiopharmaceuticals (370)
Rare diseases (1238)
Real estate (7462)
Recruiting (81)
Regulatory (30309)
Reports (77)
Research institute (2768)
Resumes & cover letters (654)
Rett syndrome (40)
RNA editing (29)
RSV (98)
Schizophrenia (194)
Series A (324)
Series B (232)
Service/supplier (28)
Sickle cell disease (126)
Special edition (32)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4370)
State (2)
Stomach cancer (21)
Supply chain (144)
Tariffs (104)
The Weekly (143)
Vaccines (1299)
Venture capital (131)
Weight loss (578)
Women's health (137)
Worklife (24)
Date
Today (148)
Last 7 days (833)
Last 30 days (3669)
Last 365 days (33151)
2026 (15453)
2025 (33221)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (397)
Arkansas (16)
Asia (52236)
Australia (9185)
California (14235)
Canada (3978)
China (1539)
Colorado (610)
Connecticut (633)
Delaware (438)
Europe (120457)
Florida (2108)
Georgia (465)
Hawaii (4)
Idaho (70)
Illinois (1230)
India (101)
Indiana (659)
Iowa (25)
Japan (580)
Kansas (143)
Kentucky (56)
Louisiana (50)
Maine (89)
Maryland (1730)
Massachusetts (10400)
Michigan (421)
Minnesota (793)
Mississippi (7)
Missouri (163)
Montana (37)
Nebraska (30)
Nevada (152)
New Hampshire (92)
New Jersey (3770)
New Mexico (35)
New York (3741)
North Carolina (1921)
North Dakota (11)
Northern California (7064)
Ohio (442)
Oklahoma (26)
Oregon (55)
Pennsylvania (2818)
Puerto Rico (30)
Rhode Island (54)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5583)
Tennessee (224)
Texas (2309)
United States (50915)
Utah (425)
Vermont (1)
Virginia (361)
Washington D.C. (89)
Washington State (1169)
West Virginia (4)
Wisconsin (157)
Wyoming (2)
There are 883,093 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lupeng Pharmaceutical’s Fourth-Generation BTK Inhibitor Rocbrutinib Approved in China for Relapsed or Refractory Mantle Cell Lymphoma
June 4, 2026
·
6 min read
Press Releases
World’s First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory Gastric Cancer and NDA Accepted by China NMPA
June 4, 2026
·
8 min read
Press Releases
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
June 4, 2026
·
6 min read
Press Releases
WellSpan Health and Philips Announce Landmark Strategic Alliance, Accelerating Innovation and Research Across Central Pennsylvania and Northern Maryland
June 4, 2026
·
5 min read
Press Releases
Press Release: Sanofi launches 2026 global employee stock purchase plan
June 4, 2026
·
5 min read
Artificial intelligence
Alnylam hops on AI train with up to $2B Inceptive partnership
Alnylam Pharmaceuticals will leverage Inceptive Nucleics’ generative machine learning models to accelerate the development of RNA interference therapies.
June 4, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development
June 4, 2026
·
6 min read
Press Releases
ALK will present data on real world-use of nasal adrenaline and key learnings from 20 years with SLIT-tablets at EAACI 2026
June 4, 2026
·
4 min read
Press Releases
Genflow Biosciences PLC Announces Notice of AGM
June 4, 2026
·
2 min read
Insights
Rethinking hair loss treatment
In this episode of Denatured, you’ll be hearing from Daniel Gil, CEO of Pelage Pharmaceuticals and Francisco Ramírez-Valle, senior vice president of immunology discovery at Eli Lilly. We dive into the long-overlooked hair loss space, exploring why true innovation has lagged, how a regenerative approach aims to reactivate dormant follicles and what early proof-of-concept means for patients.
June 4, 2026
·
1 min read
·
Jennifer C. Smith-Parker
1 of 88,310
Next
